Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|July 22, 2006
IGF-1R tyrosine kinase expression and dependency in clones of IGF-1R knockout cells (R-)Linda Rosengren, Daiana Vasilcanu, Radu Vasilcanu, et al.
Neuro-Oncology|February 13, 2010
Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastomaShucheng Yin, Ada Girnita, Thomas Strömberg, et al.
Blood|July 28, 2005
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse modelEline Menu, Helena Jernberg-Wiklund, Thomas Stromberg, et al.
Blood|September 17, 2005
IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cellsThomas Strömberg, Simon Ekman, Leonard Girnita, et al.
Investigative Ophthalmology & Visual Science|June 3, 2008
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptorMario A Economou, Jiangmei Wu, Daiana Vasilcanu, et al.
Acta Ophthalmologica|November 27, 2008
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptorMario A Economou, Jiangmei Wu, Daiana Vasilcanu, et al.
Acta Oncologica (Stockholm, Sweden)|July 11, 2015
A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trialSimon Ekman, Johan Harmenberg, Jan-Erik Frödin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2012
The HDAC inhibitor LBH589 enhances the antimyeloma effects of the IGF-1RTK inhibitor picropodophyllinMiguel Lemaire, Charlotte Fristedt, Prasoon Agarwal, et al.
Plos One|March 23, 2011
Molecular characterization of acquired tolerance of tumor cells to picropodophyllin (PPP)Jamileh Hashemi, Claire Worrall, Daiana Vasilcanu, et al.
International Journal of Cancer|June 5, 2007
Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survivalEline Menu, Helena Jernberg-Wiklund, Hendrik De Raeve, et al.
Pageof 5